‘Pfizergan’ talks prompt new anti-tax inversion rules from Treasury

Tracy Staton

The U.S. Department is rushing out a new set of guidelines on the "tax " deals that have allowed drugmakers to save big money on taxes by buying overseas rivals and moving their domiciles to friendlier jurisdictions.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS